These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma. Liu Y, Yin N, Wang X, Khoor A, Sambandam V, Ghosh AB, Fields ZA, Murray NR, Justilien V, Fields AP. Cell Rep; 2020 Jan 21; 30(3):771-782.e6. PubMed ID: 31968252 [Abstract] [Full Text] [Related]
9. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma. Fukazawa T, Guo M, Ishida N, Yamatsuji T, Takaoka M, Yokota E, Haisa M, Miyake N, Ikeda T, Okui T, Takigawa N, Maeda Y, Naomoto Y. Sci Rep; 2016 Feb 05; 6():20113. PubMed ID: 26846300 [Abstract] [Full Text] [Related]
11. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Jiang J, Li Z, Yu C, Chen M, Tian S, Sun C. Cancer Lett; 2015 Jan 28; 356(2 Pt B):962-70. PubMed ID: 25444909 [Abstract] [Full Text] [Related]
12. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. Justilien V, Jameison L, Der CJ, Rossman KL, Fields AP. J Biol Chem; 2011 Mar 11; 286(10):8149-8157. PubMed ID: 21189248 [Abstract] [Full Text] [Related]
13. Jmjd2c maintains the ALDHbri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma. Wang M, Hu Y, Cai F, Guo L, Mao Y, Zhang Y. Cancer Biol Ther; 2024 Dec 31; 25(1):2373447. PubMed ID: 38975736 [Abstract] [Full Text] [Related]